vs
Arhaus, Inc.（ARHS）与REPLIGEN CORP（RGEN）财务数据对比。点击上方公司名可切换其他公司
Arhaus, Inc.的季度营收约是REPLIGEN CORP的1.8倍（$364.8M vs $197.9M），REPLIGEN CORP净利率更高（6.7% vs 4.1%，领先2.6%），REPLIGEN CORP同比增速更快（13.6% vs 5.1%），REPLIGEN CORP自由现金流更多（$17.6M vs $-8.8M），过去两年REPLIGEN CORP的营收复合增速更高（14.4% vs 11.2%）
Arhaus, Inc.是源自美国的高端家居零售企业，总部位于俄亥俄州波士顿高地，1986年正式创立。品牌主打可持续理念与工匠级品质，产品品类丰富，采用全渠道模式面向个人消费者及企业客户，覆盖民用与商用家居场景，提供相关产品与配套服务。
Repligen是一家全球生命科学企业，专注于创新生物工艺技术与系统的研发及商业化，助力提升生物药生产效率。公司1981年成立，总部位于美国马萨诸塞州沃尔瑟姆，于纳斯达克挂牌上市，股票代码RGEN，截至2025年全球员工超1900人，主要服务生物制药领域客户。
ARHS vs RGEN — 直观对比
营收规模更大
ARHS
是对方的1.8倍
$197.9M
营收增速更快
RGEN
高出8.5%
5.1%
净利率更高
RGEN
高出2.6%
4.1%
自由现金流更多
RGEN
多$26.4M
$-8.8M
两年增速更快
RGEN
近两年复合增速
11.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $364.8M | $197.9M |
| 净利润 | $15.1M | $13.3M |
| 毛利率 | 38.1% | 52.5% |
| 营业利润率 | 5.6% | 9.0% |
| 净利率 | 4.1% | 6.7% |
| 营收同比 | 5.1% | 13.6% |
| 净利润同比 | -29.1% | 143.9% |
| 每股收益（稀释后） | $0.11 | $0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ARHSRGEN
| Q4 25 | $364.8M | $197.9M | ||
| Q3 25 | $344.6M | $188.8M | ||
| Q2 25 | $358.4M | $182.4M | ||
| Q1 25 | $311.4M | $169.2M | ||
| Q4 24 | $347.0M | $174.1M | ||
| Q3 24 | $319.1M | $154.9M | ||
| Q2 24 | $309.8M | $154.1M | ||
| Q1 24 | $295.2M | $151.3M |
净利润ARHSRGEN
| Q4 25 | $15.1M | $13.3M | ||
| Q3 25 | $12.2M | $14.9M | ||
| Q2 25 | $35.1M | $14.9M | ||
| Q1 25 | $4.9M | $5.8M | ||
| Q4 24 | $21.3M | $-30.3M | ||
| Q3 24 | $9.9M | $-654.0K | ||
| Q2 24 | $22.2M | $3.3M | ||
| Q1 24 | $15.1M | $2.1M |
毛利率ARHSRGEN
| Q4 25 | 38.1% | 52.5% | ||
| Q3 25 | 38.7% | 53.2% | ||
| Q2 25 | 41.4% | 50.0% | ||
| Q1 25 | 37.1% | 53.6% | ||
| Q4 24 | 40.0% | 26.1% | ||
| Q3 24 | 38.6% | 50.0% | ||
| Q2 24 | 40.1% | 49.8% | ||
| Q1 24 | 39.0% | 49.5% |
营业利润率ARHSRGEN
| Q4 25 | 5.6% | 9.0% | ||
| Q3 25 | 4.8% | 8.9% | ||
| Q2 25 | 13.0% | 7.6% | ||
| Q1 25 | 1.7% | 3.9% | ||
| Q4 24 | 8.2% | -17.7% | ||
| Q3 24 | 3.3% | -5.1% | ||
| Q2 24 | 9.5% | 1.0% | ||
| Q1 24 | 6.2% | 1.3% |
净利率ARHSRGEN
| Q4 25 | 4.1% | 6.7% | ||
| Q3 25 | 3.5% | 7.9% | ||
| Q2 25 | 9.8% | 8.2% | ||
| Q1 25 | 1.6% | 3.4% | ||
| Q4 24 | 6.1% | -17.4% | ||
| Q3 24 | 3.1% | -0.4% | ||
| Q2 24 | 7.2% | 2.2% | ||
| Q1 24 | 5.1% | 1.4% |
每股收益（稀释后）ARHSRGEN
| Q4 25 | $0.11 | $0.24 | ||
| Q3 25 | $0.09 | $0.26 | ||
| Q2 25 | $0.25 | $0.26 | ||
| Q1 25 | $0.03 | $0.10 | ||
| Q4 24 | $0.15 | $-0.55 | ||
| Q3 24 | $0.07 | $-0.01 | ||
| Q2 24 | $0.16 | $0.06 | ||
| Q1 24 | $0.11 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $253.4M | $767.6M |
| 总债务越低越好 | — | $542.2M |
| 股东权益账面价值 | $418.2M | $2.1B |
| 总资产 | $1.4B | $2.9B |
| 负债/权益比越低杠杆越低 | — | 0.26× |
8季度趋势，按日历期对齐
现金及短期投资ARHSRGEN
| Q4 25 | $253.4M | $767.6M | ||
| Q3 25 | $262.2M | $748.7M | ||
| Q2 25 | $234.8M | $708.9M | ||
| Q1 25 | $214.4M | $697.2M | ||
| Q4 24 | $197.5M | $757.4M | ||
| Q3 24 | $177.7M | $784.0M | ||
| Q2 24 | $174.2M | $809.1M | ||
| Q1 24 | $233.2M | $780.6M |
总债务ARHSRGEN
| Q4 25 | — | $542.2M | ||
| Q3 25 | — | $537.9M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $525.6M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益ARHSRGEN
| Q4 25 | $418.2M | $2.1B | ||
| Q3 25 | $400.4M | $2.1B | ||
| Q2 25 | $385.6M | $2.1B | ||
| Q1 25 | $348.8M | $2.0B | ||
| Q4 24 | $343.7M | $2.0B | ||
| Q3 24 | $320.6M | $2.0B | ||
| Q2 24 | $309.3M | $2.0B | ||
| Q1 24 | $285.6M | $2.0B |
总资产ARHSRGEN
| Q4 25 | $1.4B | $2.9B | ||
| Q3 25 | $1.4B | $2.9B | ||
| Q2 25 | $1.3B | $2.9B | ||
| Q1 25 | $1.3B | $2.9B | ||
| Q4 24 | $1.2B | $2.8B | ||
| Q3 24 | $1.2B | $2.8B | ||
| Q2 24 | $1.2B | $2.9B | ||
| Q1 24 | $1.2B | $2.8B |
负债/权益比ARHSRGEN
| Q4 25 | — | 0.26× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.3M | $25.7M |
| 自由现金流经营现金流 - 资本支出 | $-8.8M | $17.6M |
| 自由现金流率自由现金流/营收 | -2.4% | 8.9% |
| 资本支出强度资本支出/营收 | 5.0% | 4.1% |
| 现金转化率经营现金流/净利润 | 0.62× | 1.93× |
| 过去12个月自由现金流最近4个季度 | $59.0M | $93.9M |
8季度趋势，按日历期对齐
经营现金流ARHSRGEN
| Q4 25 | $9.3M | $25.7M | ||
| Q3 25 | $46.1M | $48.1M | ||
| Q2 25 | $34.9M | $28.6M | ||
| Q1 25 | $46.5M | $15.0M | ||
| Q4 24 | $31.7M | $39.2M | ||
| Q3 24 | $31.1M | $49.3M | ||
| Q2 24 | $47.5M | $42.2M | ||
| Q1 24 | $36.8M | $44.7M |
自由现金流ARHSRGEN
| Q4 25 | $-8.8M | $17.6M | ||
| Q3 25 | $28.0M | $43.4M | ||
| Q2 25 | $20.9M | $21.5M | ||
| Q1 25 | $18.9M | $11.4M | ||
| Q4 24 | $13.0M | $33.6M | ||
| Q3 24 | $4.6M | $42.3M | ||
| Q2 24 | $11.3M | $37.4M | ||
| Q1 24 | $10.9M | $36.4M |
自由现金流率ARHSRGEN
| Q4 25 | -2.4% | 8.9% | ||
| Q3 25 | 8.1% | 23.0% | ||
| Q2 25 | 5.8% | 11.8% | ||
| Q1 25 | 6.1% | 6.8% | ||
| Q4 24 | 3.7% | 19.3% | ||
| Q3 24 | 1.4% | 27.3% | ||
| Q2 24 | 3.6% | 24.3% | ||
| Q1 24 | 3.7% | 24.0% |
资本支出强度ARHSRGEN
| Q4 25 | 5.0% | 4.1% | ||
| Q3 25 | 5.3% | 2.5% | ||
| Q2 25 | 3.9% | 3.9% | ||
| Q1 25 | 8.9% | 2.1% | ||
| Q4 24 | 5.4% | 3.2% | ||
| Q3 24 | 8.3% | 4.5% | ||
| Q2 24 | 11.7% | 3.1% | ||
| Q1 24 | 8.8% | 5.5% |
现金转化率ARHSRGEN
| Q4 25 | 0.62× | 1.93× | ||
| Q3 25 | 3.77× | 3.23× | ||
| Q2 25 | 1.00× | 1.92× | ||
| Q1 25 | 9.53× | 2.57× | ||
| Q4 24 | 1.49× | — | ||
| Q3 24 | 3.14× | — | ||
| Q2 24 | 2.14× | 12.70× | ||
| Q1 24 | 2.44× | 21.35× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ARHS
| Sales Channel Retail | $305.7M | 84% |
| Sales Channel E Commerce | $59.2M | 16% |
RGEN
暂无分部数据
